Genotyping Stocks List

Recent Signals

Date Stock Signal Type
2021-02-25 A Fell Below 20 DMA Bearish
2021-02-25 A Fell Below 50 DMA Bearish
2021-02-25 A 180 Bearish Setup Bearish Swing Setup
2021-02-25 FLDM Calm After Storm Range Contraction
2021-02-25 FLDM Lower Bollinger Band Walk Weakness
2021-02-25 FLDM NR7 Range Contraction
2021-02-25 GNMK 1,2,3 Pullback Bullish Bullish Swing Setup
2021-02-25 GNMK MACD Bearish Signal Line Cross Bearish
2021-02-25 GNMK Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-02-25 ILMN 1,2,3 Pullback Bullish Bullish Swing Setup
2021-02-25 ILMN Fell Below 20 DMA Bearish
2021-02-25 ILMN Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-02-25 LH 1,2,3 Pullback Bullish Bullish Swing Setup
2021-02-25 LH Non-ADX 1,2,3,4 Bullish Bullish Swing Setup

Recent News for Genotyping Stocks

Date Stock Title
Feb 26 GNMK GenMark Diagnostics, Inc. (GNMK) CEO Scott Mendel on Q4 2020 Results - Earnings Call Transcript
Feb 25 GNMK GenMark Diagnostics EPS misses by $0.04, beats on revenue
Feb 25 GNMK GenMark Diagnostics Reports Fourth Quarter and Full Year 2020 Results
Feb 25 LH Jana Partners' Top 4 Trades of the 4th Quarter
Feb 25 LH Walgreens to start selling at-home COVID-19 tests
Feb 24 LH Walgreens to sell LabCorp at-home COVID-19 test
Feb 24 LH Walgreens to Make Pixel by Labcorp™ COVID-19 PCR Test Home Collection Kit Available Over-The-Counter at Stores Nationwide
Feb 24 LH LabCorp sum-of-the-parts worth $313/share with activist push, analyst says
Feb 23 LH Jana Partners nominates directors at Labcorp, including Crawford
Feb 23 LH Adaptive Bio Launches T-Cell Based COVID-19 Tests
Feb 23 LH Activist Jana Nominates Directors to Labcorp’s Board
Feb 23 LH Labcorp gains on report of Jana seeking board seats
Feb 23 LH Adaptive Biotechnologies Expands Collaboration with Labcorp to Increase Access to Growing Research and Clinical Diagnostic Portfolio
Feb 23 LH Labcorp is Scheduled to Speak at Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference
Feb 23 ILMN Genomic sequencing head calls for ‘Bio Force’ to detect virus threats
Feb 22 GNMK GenMark says its ePlex RP2 Panel can detect new coronavirus strains
Feb 22 GNMK GenMark ePlex® RP2 Panel Predicted to Detect Known SARS-CoV-2 Variants Currently in Circulation Based on in silico Analysis
Feb 22 A Agilent’s pharmDx assay approved for use in non-small cell lung cancer
Feb 22 A Agilent PD-L1 IHC 22C3 pharmDx Receives Expanded FDA Approval in Non-small Cell Lung Cancer (NSCLC)
Feb 20 GNMK The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings

Genotyping is the process of determining differences in the genetic make-up (genotype) of an individual by examining the individual's DNA sequence using biological assays and comparing it to another individual's sequence or a reference sequence. It reveals the alleles an individual has inherited from their parents. Traditionally genotyping is the use of DNA sequences to define biological populations by use of molecular tools. It does not usually involve defining the genes of an individual.
Current methods of genotyping include restriction fragment length polymorphism identification (RFLPI) of genomic DNA, random amplified polymorphic detection (RAPD) of genomic DNA, amplified fragment length polymorphism detection (AFLPD), polymerase chain reaction (PCR), DNA sequencing, allele specific oligonucleotide (ASO) probes, and hybridization to DNA microarrays or beads. Genotyping is important in research of genes and gene variants associated with disease. Due to current technological limitations, almost all genotyping is partial. That is, only a small fraction of an individual’s genotype is determined, such as with (epi)GBS (Genotyping by sequencing) or RADseq. New mass-sequencing technologies promise to provide whole-genome genotyping (or whole genome sequencing) in the future.
Genotyping applies to a broad range of individuals, including microorganisms. For example, viruses and bacteria can be genotyped. Genotyping in this context may help in controlling the spreading of pathogens, by tracing the origin of outbreaks. This area is often referred to as molecular epidemiology or forensic microbiology.
Humans can also be genotyped. For example, when testing fatherhood or motherhood, scientists typically only need to examine 10 or 20 genomic regions (like single-nucleotide polymorphism (SNPs)), which represent a tiny fraction of the human genome.
When genotyping transgenic organisms, a single genomic region may be all that needs to be examined to determine the genotype. A single PCR assay is typically enough to genotype a transgenic mouse; the mouse is the mammalian model of choice for much of medical research today.

More about Genotyping
Browse All Tags